
Tardive Dyskinesia Market Outlook 2025: Drug Class, Administration Routes & Regional Forecasts (2023–2035)
Global Tardive Dyskinesia Market Outlook 2025–2035: Trends, Drivers, and Regional Insights The global tardive dyskinesia (TD) treatment market is entering a pivotal growth phase, driven by advances in pharmacological innovation, broader clinical awareness, and increased recognition of movement disorders as…

Chronic Inducible Urticaria Market Outlook 2025–2035 | Growth Fueled by Awareness and Biologic Advances
Chronic Inducible Urticaria (CIndU) Market Outlook 2025–2035: Growth Driven by Biologic Therapies, Precision Medicine, and Rising Awareness The chronic inducible urticaria (CIndU) market is entering a transformative period, shaped by scientific advances, innovative treatment strategies, and broader awareness of this…

Dyslipidemia Market Outlook 2025-2035: Growth Driven by CVD Burden & Preventive Care
Global Dyslipidemia Market Outlook 2025–2035: Growth Driven by Rising Cardiovascular Burden, Early Diagnostics, and Therapeutic Advancements Introduction Dyslipidemia, defined as an abnormal concentration of lipids such as cholesterol and triglycerides in the blood, is one of the leading modifiable risk…

STAT Inhibitors Pipeline 2025: 18 Companies, 22 Drugs in Development
STAT Inhibitors Pipeline Insight 2025: Emerging Therapies and Market Outlook The landscape of targeted therapies in oncology and immunology continues to evolve at a rapid pace, and one of the most promising areas of innovation lies in Signal Transducer and…

Global Smart Medical Devices Market Report 2025: 2022–2024 Sales, 2025 Forecast & 2030 CAGR
Smart Medical Devices Market Outlook 2025–2030: Growth, Trends, and Future Opportunities The smart medical devices industry is entering a period of rapid expansion, fueled by technological innovations, growing healthcare needs, and the rising prevalence of chronic diseases worldwide. According to…

Global Long-Acting Drug Delivery Market Outlook to 2035: 1,200+ Patents Filed
Long-Acting Drug Delivery Technologies and Services Market Set for Strong Growth to 2035 The global pharmaceutical industry is in the midst of a transformation, with long-acting drug delivery technologies rapidly emerging as one of the most promising innovations. According to…

Online Bans Could Backfire: Haypp Expert Urges More Access to Alternatives
Online Sales Bans Risk Backfiring: Haypp Group Calls for Greater Access to Safer Nicotine Alternatives American smokers who are searching for safer alternatives to cigarettes face a critical challenge: limited access, restrictive policies, and a regulatory environment that often puts…

UF Health Extends Partnership to Provide Medical Care for Team USA Athletes Through 2028
UF Health Extends Role as Key Medical Partner for Team USA Through 2028 University of Florida Health (UF Health) has strengthened its commitment to supporting elite athletes by extending its agreement with the United States Olympic & Paralympic Committee (USOPC).…

Henry Schein, Henry Schein One Launch ‘Linkit’ for Seamless Dentrix Digital Workflow
Henry Schein and Henry Schein One Unveil “LinkIt” to Create Seamless Digital Workflows for Dentrix Practices Henry Schein, Inc. (Nasdaq: HSIC) and its software subsidiary, Henry Schein One, have introduced LinkIt™, a new digital solution that promises to revolutionize the…

MinuteClinic broadens virtual mental health care services
MinuteClinic Expands Virtual Mental Health Services to Address Growing Demand Across the U.S. Mental health challenges have become an increasingly urgent issue in the United States, affecting people across all age groups and demographics. According to a recent CVS Health…

Otsuka Wins Japan’s First Approval for Paradise Ultrasound Renal Denervation in Resistant Hypertension
Otsuka Medical Devices Secures First Japanese Approval for Paradise™ Ultrasound Renal Denervation System to Treat Resistant Hypertension Otsuka Medical Devices Co., Ltd. has achieved a significant regulatory milestone with the announcement that its Paradise™ Ultrasound Renal Denervation (uRDN) system has…

Stacy Giles Appointed COO of Greater Boston Urology, a U.S. Urology Partners Affiliate
Stacy Giles Appointed Chief Operating Officer of Greater Boston Urology, Building on Legacy of Growth and Innovation Greater Boston Urology (GBU), the largest urology group practice in Massachusetts and an affiliate of U.S. Urology Partners, has announced the appointment of…

